×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Commit To Buy TG Therapeutics At $8, Earn 14.4% Using Options
Nasdaq
Investors considering a purchase of TG Therapeutics Inc (Symbol: TGTX) shares, but cautious about paying the going market price of...
2 days ago
Despite shrinking by US$192m in the past week, TG Therapeutics (NASDAQ:TGTX) shareholders are still up 131 ...
Yahoo Finance
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
3 days ago
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of ...
GlobeNewswire
NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced presentations highlighting study designs...
2 days ago
TG Therapeutics, Inc. (NASDAQ:TGTX) Surges 25% Yet Its Low P/S Is No Reason For Excitement
Simply Wall Street
Those holding TG Therapeutics, Inc. ( NASDAQ:TGTX ) shares would be relieved that the share price has rebounded 25% in...
4 days ago
TG Therapeutics, Inc. (NASDAQ:TGTX) Holdings Raised by Corient Private Wealth LLC
MarketBeat
Corient Private Wealth LLC boosted its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 231.6% during the fourth quarter,...
9 hours ago
TG Therapeutics Shows Rising Price Performance With Jump To 81 RS Rating
Investor's Business Daily
On Wednesday, TG Therapeutics (TGTX) got an upgrade to its Relative Strength (RS) Rating, from 76 to 81. IBD's unique rating tracks price...
1 week ago
Precision and TG Therapeutics conclude Azer-Cel license deal
Pharmaceutical Technology
Precision BioSciences and TG Therapeutics concluded a licensing agreement for developing azercabtagene-zapreleucel for autoimmune diseases.
4 months ago
TG Therapeutics (TGTX) Stock Sinks As Market Gains: What You Should Know
Yahoo Movies Canada
TG Therapeutics (TGTX) closed the most recent trading day at $18.43, moving -0.27% from the previous trading session.
1 day ago
Should You Worry About TG Therapeutics, Inc.'s (NASDAQ:TGTX) CEO Pay?
Yahoo News UK
Mike Weiss has been the CEO of TG Therapeutics, Inc. (NASDAQ:TGTX) since 2011. First, this article will compare CEO...
3 days ago
TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and ...
GlobeNewswire
TGTX 2021 Logo · TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of...
4 months ago